BioScience Health Innovations, Inc.
BHIC
$4.13
-$0.05-1.20%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.21M | 5.69M | 4.73M | 4.17M | 2.79M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.21M | 5.69M | 4.73M | 4.17M | 2.79M |
| Cost of Revenue | 2.38M | 2.45M | 1.72M | 1.43M | 824.10K |
| Gross Profit | 2.83M | 3.24M | 3.01M | 2.73M | 1.97M |
| SG&A Expenses | 2.77M | 2.52M | 2.12M | 1.78M | 1.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.15M | 4.97M | 3.84M | 3.22M | 2.23M |
| Operating Income | 62.30K | 719.00K | 885.70K | 950.70K | 567.20K |
| Income Before Tax | 62.30K | 719.00K | 885.70K | 950.70K | 567.20K |
| Income Tax Expenses | 77.00K | 77.00K | -- | -- | -- |
| Earnings from Continuing Operations | -0.01 | 0.64 | 0.89 | 0.95 | 0.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.60K | 642.10K | 885.70K | 950.70K | 567.20K |
| EBIT | 62.30K | 719.00K | 885.70K | 950.70K | 567.20K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.03 | 0.05 | 0.06 | 0.02 |
| Normalized Basic EPS | 0.00 | 0.02 | 0.03 | 0.04 | 0.01 |
| EPS Diluted | 0.00 | 0.03 | 0.05 | 0.06 | 0.02 |
| Normalized Diluted EPS | 0.00 | 0.02 | 0.03 | 0.04 | 0.01 |
| Average Basic Shares Outstanding | 44.31M | 76.85M | 76.65M | 76.15M | 75.57M |
| Average Diluted Shares Outstanding | 44.42M | 77.38M | 77.60M | 77.51M | 76.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |